CA2170485C - Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine - Google Patents

Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine Download PDF

Info

Publication number
CA2170485C
CA2170485C CA002170485A CA2170485A CA2170485C CA 2170485 C CA2170485 C CA 2170485C CA 002170485 A CA002170485 A CA 002170485A CA 2170485 A CA2170485 A CA 2170485A CA 2170485 C CA2170485 C CA 2170485C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
caffeine
composition according
amino acid
mixtures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002170485A
Other languages
English (en)
Other versions
CA2170485A1 (fr
Inventor
Sekhar Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2170485A1 publication Critical patent/CA2170485A1/fr
Application granted granted Critical
Publication of CA2170485C publication Critical patent/CA2170485C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compositions et procédés servant à produire un effet analgésique et/ou anti-inflammatoire par administration d'une quantité efficace d'une composition composée de certains sels d'acide aminé d'agents anti-inflammatoires non stéroïdiens à base d'acide propionique avec une quantité de caféine suffisante pour accélérer l'efficacité de l'action.
CA002170485A 1993-09-07 1994-08-24 Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine Expired - Fee Related CA2170485C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11738993A 1993-09-07 1993-09-07
US117,389 1993-09-07
PCT/US1994/009582 WO1995007079A1 (fr) 1993-09-07 1994-08-24 Compositions contenant un sel d'acide amine d'agents anti-inflammatoires non steroidiens a base d'acide propionique et de la cafeine

Publications (2)

Publication Number Publication Date
CA2170485A1 CA2170485A1 (fr) 1995-03-16
CA2170485C true CA2170485C (fr) 2000-11-07

Family

ID=22372657

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002170485A Expired - Fee Related CA2170485C (fr) 1993-09-07 1994-08-24 Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine

Country Status (6)

Country Link
EP (1) EP0717624A1 (fr)
JP (1) JPH09502202A (fr)
AU (1) AU7604194A (fr)
BR (1) BR9407415A (fr)
CA (1) CA2170485C (fr)
WO (1) WO1995007079A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5863902A (en) * 1995-01-06 1999-01-26 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
AU718030B2 (en) * 1996-05-20 2000-04-06 G.D. Searle & Co. Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
WO1999052528A1 (fr) * 1998-04-11 1999-10-21 Errekappa Euroterapici S.P.A. Preparations pharmaceutiques a base de sels de ketoprofene hydrosoluble et applications correspondantes
PL345340A1 (en) 1998-07-09 2001-12-17 Warner Lambert Co Compositions comprising gaba analogs and caffeine
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
TWI313598B (en) * 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US9629847B2 (en) 2011-11-23 2017-04-25 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
US9149474B2 (en) 2011-11-23 2015-10-06 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
EP3406239B1 (fr) * 2017-05-22 2021-10-20 Epifarma Srl Solutions de sel de lysine de kétoprofène agréables au goût

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
WO1991006295A1 (fr) * 1989-11-06 1991-05-16 Sepracor, Inc. Composition analgesique contenant du s(+) flurbiprofene optiquement pur
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
EP0663819A4 (fr) * 1992-09-29 1998-05-27 Merck & Co Inc Association d'ibuprofene et de cafeine.
AU672279B2 (en) * 1992-12-21 1996-09-26 Procter & Gamble Company, The Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
WO1994016703A1 (fr) * 1993-01-29 1994-08-04 Merck & Co., Inc. Combinaison de cyclobenzaprine et de cafeine utilisee comme myorelaxant

Also Published As

Publication number Publication date
EP0717624A1 (fr) 1996-06-26
WO1995007079A1 (fr) 1995-03-16
AU7604194A (en) 1995-03-27
BR9407415A (pt) 1996-11-12
JPH09502202A (ja) 1997-03-04
CA2170485A1 (fr) 1995-03-16

Similar Documents

Publication Publication Date Title
WO1995007103A1 (fr) Compositions contenant un sel d'acide amine d'un agent anti-inflammatoire non steroidien a base d'acide propionique et au moins un decongestionnant ou un expectorant ou un antihistaminique ou un antitussif
AU678561B2 (en) Pharmaceutical compositions and methods for treating cold symptoms
US5648358A (en) Compositions and methods for treating respiratory disorders
EP0717624A1 (fr) Compositions contenant un sel d'acide amine d'agents anti-inflammatoires non steroidiens a base d'acide propionique et de la cafeine
AU8744398A (en) Compositions and methods for treating respiratory disorders
JP2002520286A (ja) Ｇａｂａ類縁体及びカフェインを含んでなる組成物
AU672279B2 (en) Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
EP0674527A1 (fr) Utilisation d'antipodes s(+) d'agents analgesiques dans la fabrication d'une composition de traitement de troubles respiratoires
WO1997004808A1 (fr) Compositions contenant des analgesiques et des antihistaminiques et procedes de traitement d'affections respiratoires
WO1992004022A1 (fr) Utilisation de compositions contenant des derives de l'acide 2-(6'-substitue-2'-naphtyle)-acetique pour le traitement de troubles respiratoires
CA2090234C (fr) Methode permettant d'obtenir un effet analgesique ameliore
CA2010022C (fr) Composes anesthesiques oraux
AU8915891A (en) Dextromethorphan antitussive compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed